Deutsch English Français

Contact

EP1501485

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1501485

EP1501485 - HIGH DRUG LOAD TABLET [Right-click to bookmark this link]
Status	Patent revoked Status updated on 09.05.2020 Database last updated on 20.12.2024
Most recent event Tooltip	24.06.2022	Lapse of the patent in a contracting state	published on 27.07.2022 [2022/30]
Applicant(s)	For:BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT
	[N/P]
Former [2005/42]	For:BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT
Former [2005/05]	For:BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT
Inventor(s)	01 / LUFTENSTEINER, Christian-Peter Am Rheinpark 2 79576 Weil am Rhein / DE
	02 / BIANCHI, Jean-Claude Rue Kellergraben 68730 Blotzheim / FR
	03 / OGORKA, Jörg Im Steinbrunnen 19/3 79585 Steinen / DE
	04 / KALB, Oskar Belchenstrasse 9 79539 Lörrach / DE
	[2005/05]
Representative(s)	Warner, James Alexander, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[2014/12]
Former [2009/51]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Former [2009/01]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Former [2005/12]	de Weerd, Petrus G.W., et al Novartis International AG Corporate Intellectual Property 4002 Basel / CH
Former [2005/05]	Grubb, Philip William, et al Novartis AG, Corporate Intellectual Property 4002 Basel / CH
Application number, filing date	03722519.0	22.04.2003
	[2005/05]
	WO2003EP04151
Priority number, date	GB20020009265	23.04.2002 Original published format: GB 0209265
	[2005/05]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO03090720
	Date:	06.11.2003
	Language:	EN
	[2003/45]
	Type:	A1 Application with search report
	No.:	EP1501485
	Date:	02.02.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 06.11.2003 takes the place of the publication of the European patent application.
	[2005/05]
	Type:	B1 Patent specification
	No.:	EP1501485
	Date:	26.09.2007
	Language:	EN
	[2007/39]
Search report(s)	International search report - published on:	EP	06.11.2003
Classification	IPC:	A61K9/16, A61K9/26, A61K9/28, A61K47/32, A61K47/38, A61K31/505	[2005/05]
	CPC:	A61K31/506 (EP,KR,NO,US); A61K9/20 (KR,NO); A61K31/185 (EP,US); A61K31/505 (EP,US); A61K47/32 (NO); A61K9/2009 (US); (+) A61K9/2013 (EP,US); A61K9/2027 (US); A61K9/2054 (EP,US); A61K9/2072 (US); A61K9/2095 (US); A61K9/28 (US); A61P13/08 (EP); A61P35/00 (EP); A61P35/02 (EP); B29C43/003 (US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/05]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	TABLETTE MIT HOHEM WIRKSTOFFGEHALT	[2005/05]
	English:	HIGH DRUG LOAD TABLET	[2005/05]
	French:	COMPRIME A FORTE CHARGE EN SUBSTANCE MEDICAMENTEUSE	[2005/05]
Entry into regional phase	23.11.2004	National basic fee paid
	23.11.2004	Designation fee(s) paid
	23.11.2004	Examination fee paid
Examination procedure	28.07.2003	Request for preliminary examination filed International Preliminary Examining Authority: EP
	23.11.2004	Examination requested [2005/05]
	11.05.2007	Amendment by applicant (claims and/or description)
	20.07.2007	Communication of intention to grant the patent
	08.08.2007	Fee for grant paid
	08.08.2007	Fee for publishing/printing paid
	17.10.2014	Observations by third parties
Opposition(s)	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Elkington and Fife LLP, et al, et al Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative August Debouzy 7, rue de Téhéran 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		10 06.10.2017 29.06.2018 INTERVENTION WITHDRAWN Accord Healthcare Sage House, 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		[N/P]
	Former [2018/51]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Elkington & Fife LLP, et al, et al Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative August Debouzy 6-8, avenue de Messine 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		10 06.10.2017 29.06.2018 INTERVENTION WITHDRAWN Accord Healthcare Sage House, 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2018/32]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative August Debouzy 6-8, avenue de Messine 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		10 06.10.2017 29.06.2018 INTERVENTION WITHDRAWN Accord Healthcare Sage House, 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2018/17]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative August Debouzy 6-8, avenue de Messine 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		10 06.10.2017 11.10.2017 INTERVENTION Accord Healthcare Sage House, 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2017/46]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Kling, Edouard, et al, et al August & Debouzy avocats 6-8, avenue de Messine 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		10 06.10.2017 11.10.2017 INTERVENTION Accord Healthcare Sage House, 319 Pinner Road North Harrow Middlesex HA1 4HF / GB Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2016/29]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Kling, Edouard, et al, et al August & Debouzy avocats 6-8, avenue de Messine 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2016/10]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Kling, Edouard, et al, et al August & Debouzy avocats 6-8, avenue de Messine 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Gill Jennings & Every LLP, et al, et al The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Hoffmann Eitle, et al, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2014/43]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Kling, Edouard, et al, et al August & Debouzy avocats 6-8, avenue de Messine FR-75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative HOFFMANN EITLE, et al, et al Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE
	Former [2012/26]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Bird & Bird LLP Van Alkemadelaan 700 2597 AW Den Haag / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Kling, Edouard, et al, et al August & Debouzy avocats 6-8, avenue de Messine FR-75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative HOFFMANN EITLE, et al, et al Patent- und Rechtsanwälte Arabellastraße 4 81925 München / DE
	Former [2011/19]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Bird & Bird LLP Van Alkemadelaan 700 2597 AW Den Haag / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Kling, Edouard, et al, et al August & Debouzy avocats 6-8, avenue de Messine FR-75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2011/19]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Bird & Bird LLP Van Alkemadelaan 700 2597 AW Den Haag / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Unsöldstrasse 2 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Unsöldstrasse 2 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2010/31]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Bird & Bird LLP Van Alkemadelaan 700 2597 AW Den Haag / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2009/45]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2009/35]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2009/14]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 23.02.2009 WITHDRAWN Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street GB-London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2008/39]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 17.07.2008 ADMISSIBLE Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street GB-London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2008/38]
	Opponent(s)	01 23.06.2008 04.07.2008 ADMISSIBLE Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
		02 23.06.2008 04.07.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL
		03 25.06.2008 04.07.2008 ADMISSIBLE CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 04.07.2008 ADMISSIBLE Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		05 26.06.2008 15.07.2008 ADMISSIBLE Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 17.07.2008 ADMISSIBLE Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Clarke, Lionel Paul, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street GB-London EC2M 7LH / GB
		07 26.06.2008 15.07.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 23.07.2008 ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		09 26.06.2008 15.07.2008 ADMISSIBLE Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2008/32]
	Opponent(s)	01 23.06.2008 Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
		02 23.06.2008 ADMISSIBLE Synthon B.V./Genthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL
		03 25.06.2008 CHEMAGIS LTD. 31 Lehi St. P.O.B. 2231 51100 Bnei Brak / IL Opponent's representative Pochart, François, et al, et al Hirsch & Associés 58, Avenue Marceau 75008 Paris / FR
		04 25.06.2008 Teva Pharmaceutical Industries Ltd. et al. 5 Basel Street Petah Tikvah 49131 / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		05 26.06.2008 Hightone Management Limited 7 Eldon Street London EC2M 7LH / GB Opponent's representative Jappy, John William Graham, et al, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB
		06 26.06.2008 Bucks Teresa Anne 34 Bridge Street Reading RG1 2LU / GB Opponent's representative Pluckrose, Anthony William, et al, et al Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT / GB
		07 26.06.2008 ADMISSIBLE Instytut Farmaceutyczny ul. Rydygiera 8 01-793 Warszawa / PL Opponent's representative Krzywdzinska, Ewa, et al, et al Instytut Farmaceutyczny, ul. Rydygiera 8 01-793 Warszawa / PL
		08 26.06.2008 Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE
		09 26.06.2008 Zentiva a.s. U kabelovny 130 102 37 Praha 10 / CZ Opponent's representative Wolf, Matthias, et al, et al Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE
	Former [2008/31]
	Opponent(s)	01 23.06.2008 Actavis Group hf. Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative Gillard, Richard Edward, et al, et al Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
	deleted	Deletion: Legal effect of rejection of opposition [ N /P ]
	31.07.2008	Invitation to proprietor to file observations on the notice of opposition
	14.04.2009	Reply of patent proprietor to notice(s) of opposition
	07.12.2010	Date of oral proceedings
	17.01.2011	Despatch of minutes of oral proceedings
	17.01.2011	Date of despatch of rejection of opposition
	15.05.2017	Date of oral proceedings
	16.10.2017	Despatch of interlocutory decision in opposition
	16.10.2017	Despatch of minutes of oral proceedings
	26.11.2019	Legal effect of revocation of patent [2020/25]
	17.02.2020	Despatch of communication that the patent will be revoked
Appeal following opposition	15.12.2017	Appeal received No. T0031/18
	26.02.2018	Statement of grounds filed
	26.11.2019	Result of appeal procedure: revocation of the patent
	02.01.2018	Appeal received No. T0031/18
	13.02.2018	Statement of grounds filed
	26.11.2019	Result of appeal procedure: revocation of the patent
	18.03.2011	Appeal received No. T0571/11
	27.05.2011	Statement of grounds filed
	01.12.2015	Result of appeal procedure: continuation of opposition procedure
	17.03.2011	Appeal received No. T0571/11
	27.05.2011	Statement of grounds filed
	01.12.2015	Result of appeal procedure: continuation of opposition procedure
	16.03.2011	Appeal received No. T0571/11
	27.05.2011	Statement of grounds filed
	01.12.2015	Result of appeal procedure: continuation of opposition procedure
	08.03.2011	Appeal received No. T0571/11
	27.05.2011	Statement of grounds filed
	01.12.2015	Result of appeal procedure: continuation of opposition procedure
	15.03.2011	Appeal received No. T0571/11
	26.05.2011	Statement of grounds filed
	01.12.2015	Result of appeal procedure: continuation of opposition procedure
	16.03.2011	Appeal received No. T0571/11
	17.05.2011	Statement of grounds filed
	01.12.2015	Result of appeal procedure: continuation of opposition procedure
	01.12.2015	Date of oral proceedings
	14.12.2015	Minutes of the oral proceedings despatched
	26.11.2019	Date of oral proceedings
	29.11.2019	Minutes of the oral proceedings despatched
Fees paid	Renewal fee
	02.05.2005	Renewal fee patent year 03
	02.05.2006	Renewal fee patent year 04
	02.05.2007	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	TR	22.04.2017
	[2022/30]
Cited in	International search	[DA]EP0564409 (CIBA GEIGY AG [CH]) [DA] 1-15 * page 13, line 45 - line 52 * * page 14, line 1 - line 4 ** examples 32,33 *;
		[DY]WO9903854 (NOVARTIS AG [CH], et al) [DY] 1-15 * page 17, paragraph 2 * * page 18, paragraph 1 * * example 4 *;
		[Y]WO0147507 (NOVARTIS AG [CH], et al) [Y] 1-15 * See formula III; page 18, paragraph 2 * * page 34, paragraphs 2,3 * * page 35, paragraph 1 * * example 8 *
	other	CH176497
		US4562024
		WO9008542
		EP0189114
		CA2093203
		EP0564409
		US5521184
		WO9622082
		US5605889
		US5635208
		WO9749394
		EP0890359
		WO9903854
		US5879706
		WO9915155
		WO9925321
		WO0027398
		US6106865
		WO0059500
		WO0119363
		WO0147507
		US2001014352
		WO0170225
		US6342247
		EP0747050
		- MIMS, Haymarket Medical Publications, (20020100), pages 7,319 - 320, XP055319357
		- "Chapter 45", Gennaro A.R., Remington: The Science and Practice of Pharmacy. 20th ed., (20000000), pages 858 - 893, XP055301374
		- "Chapter 18 and 39", Aulton M.E., Pharmaceutics - The Science of Dosage form Design. 1st ed., Churchill Livingston, (19880000), pages 304-321,647 - 668, XP055317802
		- "Chapter 11", Lachman L. et al, The Theory and Practice of Industrial Pharmacy. 2nd ed., Lea & Febiger, (19760000), pages 321 - 358, XP055317806
		- Liebermann H.A., Pharmaceutical Dosage Forms: Tablets. 2nd ed., Rev and Exp., Marcel Dekker, (19890000), vol. 1, pages 79-81,148 - 149, XP055319834
		- "Chapters 3 and 4", Liebermann H.A. et al, Pharmaceutical Dosage Forms: Tablets. 2nd ed., Marcel Dekker, (19890000), vol. 1, pages 131 - 195-246, XP055317823
		- "Mixing", Liebermann H.A. et al, Pharmaceutical Dosage Forms: Tablets. 2nd ed. Rev. and exp., Marcel Dekker, (19890000), vol. 2, pages 7 - 9, XP055319349
		- Ritschel W.A. et al, Die Tablette Handbuch der Entwicklung, Herstellung und Qualitatssicherung, EDITIO CANTOR VERLAG, (20020000), pages 64 - 65, XP055317841
		- H. A. LIEBERMAN et al., Pharmaceutical dosage forms: Tablets, Marcel Dekker, (19890000), vol. 1, pages 113 - 115,121-122,137,148-151, XP055317887
		- Parikh D.M., Handbook of Pharmaceutical Granulation Technology, Marcel Dekker, (19970000), pages 7 - 14, XP055317900
		- BECKER et al., "Effectiveness of Binders in Wet Granulation: A Comparison Using Model Formulations of Different Tabletability", Drug Developmental Industrial Pharmacy, (19970000), vol. 23, no. 8, pages 791 - 808, XP009051043 DOI: http://dx.doi.org/10.3109/03639049709150550
		- Nürnberg E. et al, Hagers Handbuch, der pharmazeutischen Praxis 5., vollständig neubearbeitete Auflage, Springer-Verlag, (19910000), page 725, XP055317912
		- "Die Tablettenbestandteile", Wolfgang A Ritschel, Bauer Annette, Die Tablette. Grundlagen und Praxis des Tablettierens, Granulierens und Dragierens, EDITIO CANTOR VERLAG, (19660000), vol. 7, pages 77 - 79, XP055317925
		- CHOWHAN ZT; YANG IC, "Effect of Intergranular versus Intragranular Cornstarch on Tablet Friability and In Vitro Dissolution", J Pharm Sei, (19830900), vol. 72, no. 9, pages 983 - 988, XP055317952 DOI: http://dx.doi.org/10.1002/jps.2600720903
		- GENNARO A.R. ET AL, Remington's Pharmaceutical Sciences, (19850000), vol. 19, pages 1614 - 1615,1623, XP002112349
		- "Oral solids", Walter Lund, THE PHARMACEUTICAL CODEX. Principles and Practice of Pharmaceutics. 12th ed., THE PHARMACEUTICAL PRESS, (19940000), pages 2 - 23,198-204, XP055318927
		- Walter Lund, The Pharmaceutical Codex. Principles and Practice of Pharmaceutics. 12th ed., The Pharmaceutical Press, (19940000), pages 2-21,198 - 203, XP055318927
		- The United States Pharmacopei USP 24 NF 19, United States Pharmacopeil Convention, (20000101), pages 2117 - 2121, XP055319688
		- The United States Pharmacopei USP 24 NF 19, United States Pharmacopeil Convention, (20000101), pages 2051 - 2059, XP055319696
		- Wade A. et al, Handbook of Pharmaceutical Excipients. 2nd ed., The Pharmaceutical Press, (19940000), pages 84 - 87,229-232,143-144,424-427,280-282, XP055318954
		- Physician's Desk Reference. 56th ed., Medical Economics Company, (20020000), page 334,3076, XP055319385
		- RITSCHEL W.A., Die Tablette Grundlagen und Praxis des Tablettierens, Granulierens und Dragierens, EDITIO CANTOR, (19660000), pages 77 - 79, XP055297920
		- DEAK D. et al., "Use of different cellulose derivatives for the preparation of tablets with a high active agent content", S.T.P. Pharma Sciences, (19991100), vol. 9, no. 6, pages 525 - 529, XP055319374
		- MUTI H. et al., "Effects of Binders and Moisture Content on the Disintegration, Hardness and Friability of Paracetamol and Orphenadrine Citrate Tablets", Drug Development and Industrial Pharmacy, (19890000), vol. 15, no. 12, pages 2017 - 2035, XP009114405 DOI: http://dx.doi.org/10.3109/03639048909052516
		- "Neoplastic disorders", MIMS, Haymarket Medical Publications, (20040400), page 1,338, XP055319335
		- "Neoplastic disorders", MIMS, Haymarket Medical Publications, (20041000), page 1,353, XP055319337
		- Novartis, "GLEEVEC TM (imatinib mesylate) Capsules", Package Insert, (20010905), pages 1 - 14, XP055319829
		- Novartis, "Glivec 100 mg capsules, hard", Product Specifications, (20010000), pages 1 - 13, XP055319823
		- COHEN, MARTIN H. et al, "Gleevec™ for the Treatment of Chronic Myelogenous Leukemia: U.S. Food and Drug Administration Regulatory Mechanisms, Accelerated Approval, and Orphan Drug Status", The Oncologist, (20021000), vol. 7, no. 5, pages 390 - 392, XP055319341 DOI: http://dx.doi.org/10.1634/theoncologist.7-5-390
		- "Unit 7.3: Overview of Drug Product Development", Kathleen M. Lee, Current Protocols in Pharmacology, (20010000), pages 7.3.1 - 7.3.10, XP055319345
		- Jens T. Carstensen, Advanced Pharmaceutical Solids, MARCEL DEKKER, (20010000), page 375, XP055319348
		- Ngoc Do et al, "Narrowing the gap between clinical capsule formulations and commercial film-coated tablets", Pharmaceutical Technology Europe, (20090501), vol. 21, no. 5, XP055319842
		- Mark Gibson, Pharmaceutical Preformulation and Formulation A Practical Guide from Candidate Drug Selection to Commercial Dosage Form, Taylor & Francis, (20010000), pages 441 - 446, XP055318863 DOI: http://dx.doi.org/10.1201/b14413-15
		- Michael E. Aulton, Pharmaceutics, The Science of dosage Form Design. 2nd ed., CHURCHILL LIVINGSTONE, (20020000), pages 449 - 450, XP055318851
		- "Crospovidone", Kibbe A.H., Handbook of PHARMACEUTICAL EXCIPIENTS. 3rd ed., American Pharmaceutical Association, (20000000), pages 163 - 164, XP002471272
		- Lieberman Herbert A. et al, The Theory and Practice of Industrial Pharmacy. 3rd ed., LEA & FEBIGER, (19760000), pages 293 - 294, XP055318771
		- Zariana Nikolova et al, "Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules", Cancer Chemotherapy and Pharmacology, (20040500), vol. 53, no. 5, pages 433 - 438, XP055128465 DOI: http://dx.doi.org/10.1007/s00280-003-0756-z
		- Lieberman H.A. et al, Pharmaceutical Dosage Forms. Tablets. 2nd ed., rev. and exp., MARCEL DEKKER, (19890000), vol. 1, page 94, XP055318759
		- UNITED STATES PHARMACOPEIA USP 25 NF 20, UNITED STATES PHARMACOPEIAL CONVENTION, (20020101), page 2255, XP055319325
	- Alfonso R. Gennaro, Remington's Pharmaceutical Sciences. 17th ed., Mack Publishing, (19850000), page 1603,1614, XP055318744
	- BAUER; FROMMING; FUHRER, Lehrbuch der Pharmazeutischen Technologie. 6th ed., Wissenschaftliche Verlagsgesellschaft, (20060000), pages 333 - 335, XP055318734
	- Alfonso R. Gennaro, Remington's Pharmaceutical Sciences. 17th ed., Mack Publishing, (19850000), page 1764,1771, XP055318740
	US4562024
	CA2093203
	EP0564409
	US5521184
	US5605889
	US5635208
	WO9903854
	US5879706
	WO9915155
	WO9925321
	EP0564409
	WO0027398
	WO0147507
	US2001014352
	WO0170225
	PL199779B
	- PHARMACEUTICAL SCIENCES, MACK PUBLISHING COMPANY, (1985), page 1603,1614,1764,1771, XP003035075
	- KURT H. BAUER ET AL, LEHRBUCH DER PHARMAZEUTISCHEN TECHNOLOGIE. MIT EINER EINFÜHRUNG IN DIE BIOPHARMAZIE, WISSENSCHAFTLICHE VERLAGSGES, (20020801), pages 331,334 - 335, XP003035076
	Opposition	US5368864
		WO9903854
		WO9944580
		WO9951239
		CA2239931
		WO0141733
		WO0147507
		WO0176573
		WO0197805

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p